Evidence map›Paper›PMID 42145968›Full record

ArticleMaterials today (Kidlington, England)2025

Biofabrication of engineered tissues by 3D bioprinting of tissue specific high cell-density bioinks.

Oju Jeon, Hyoeun Park, J Kent Leach, Eben Alsberg

Abstract read
In one paragraph

Article in Materials today (Kidlington, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Oju JeonDepartment of Biomedical Engineering, University of Illinois Chicago, Chicago, IL 60612, USA.
Hyoeun ParkDepartment of Biomedical Engineering, University of Illinois Chicago, Chicago, IL 60612, USA.
J Kent LeachDepartment of Biomedical Engineering, University of California Davis, Davis, CA 95616, USA.
Eben AlsbergDepartment of Biomedical Engineering, University of Illinois Chicago, Chicago, IL 60612, USA.

Funding

Oxygen generating bioinks for 3D printed bone implantsR01AR074234 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHIN, SU RYON · 2018 to 2022
$1.9M
Identifying the superior ossification pathway for tissue engineered approaches to long bone repairR01AR079211 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEACH, J. KENT · 2021 to 2025
$1.9M
Individual cell bioprinting to generate multi-tissue type condensations for osteochondral tissue regenerationR01AR081448 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Eben Alsberg, Oju Jeon · 2023 to 2026
$1.6M
NIAMS NIH HHS R01 AR074234NIAMS NIH HHS R01 AR079211NIAMS NIH HHS R01 AR081448RRD VA I01 RX004288
6 · The paper itself

Abstract

Bioprinting of high cell-density bioinks is a promising technique for cellular condensation-based tissue engineering and regeneration medicine. However, it is still difficult to create precisely controlled complex structures and organization of tissues with high cell-density bioink-based bioprinting for tissue specific condensation. In this study, we present newly biofabricated tissues from directly assembled, tissue specific, high cell-density bioinks which have been three-dimensionally printed into a photocrosslinkable and biodegradable hydrogel microparticle supporting bath. Three types of tissue specific high cell-density bioinks have been prepared with individual stem cells or stem cell aggregates by incorporation of growth factor-loaded gelatin microparticles. The bioprinted tissue specific high cell-density bioinks in the photocrosslinked microgel supporting bath condense together and differentiate down tissue-specific lineages to form multi-phase tissues (e.g., osteochondral tissues). By changing the growth factors and cell types, these tissue specific high cell-density bioinks enable engineering of various functional tissues with controlled architecture and organization of cells.

Indexed as

BiofabricationBioprintingCell printingHigh cell-density bioinkHydrogelSlurry bath

Identifiers

PMID42145968
PMCPMC13178464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.